Rankings
▼
Calendar
NVAX Q4 2020 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena
NVAX
Novavax, Inc.
$2B
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$280M
+3072.2% YoY
Gross Profit
$280M
100.0% margin
Operating Income
-$183M
-65.4% margin
Net Income
-$178M
-63.5% margin
EPS (Diluted)
$-2.70
QoQ Revenue Growth
+78.1%
Cash Flow
Operating Cash Flow
-$129M
Free Cash Flow
-$171M
Stock-Based Comp.
$50M
Balance Sheet
Total Assets
$1.6B
Total Liabilities
$955M
Stockholders' Equity
$627M
Cash & Equivalents
$553M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$280M
$9M
+3072.2%
Gross Profit
$280M
$9M
+3072.2%
Operating Income
-$183M
-$29M
-537.0%
Net Income
-$178M
-$32M
-457.9%
Revenue Segments
Government Contract
$174M
62%
Grant
$105M
38%
← FY 2020
All Quarters
Q1 2021 →